Do you suffer from Type 1 Diabetes? If you live in L.A., you might qualify for a research study being conducted by National Research Institute. Qualified participants will be reimbursed for their time and travel.
Purpose of the Study:
The inTandem1 trial is evaluating an investigational oral product that is given by mouth and may improve your blood glucose levels without increasing your risk of hypoglycemia.
About the Study:
This clinical research study is being conducted to evaluate the safety and potential effectiveness of an investigational oral product for Type 1 Diabetes. This product is taken by mouth inTandem with your current insulin regimen and may help manage your blood glucose levels without increasing your risk of hypoglycemia.
If you choose to participate in the study, the following will be performed at screening to determine if you are eligible:
• Medical History
• Complete physical exam
• Laboratory blood tests
Qualified participants will attend approximately 12 office visits and receive periodic follow-up phone calls over a 15 month period. You will also be required to keep a study diary throughout the duration of your study participation.
Who Can Participate in the Study:
As with all clinical research studies, you must meet criteria determined by the study protocol. You may be eligible to participate in this study if you:
• Are 18 years old or older
• Have a confirmed diagnosis of Type 1 Diabetes Mellitus
• Have A1C levels 7-11%
For more information, please call: 866-306-8676 or visit nriclinicalstudies.com